Barry Callebaut AG BARN.SW
Composite 50/100; the shares have moved about 36% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 27/100 — a moderate mark against it.
Valuation ranks 72/100 — a moderate point in its favour. Growth ranks 64/100 — a moderate point in its favour.
Momentum ranks 27/100 — a moderate mark against it. Income ranks 44/100 — a slight mark against it. Quality ranks 44/100 — a slight mark against it.
What the company does Barry Callebaut AG (BARN.SW) is a global leader in chocolate and cocoa products, serving food manufacturers, artisans, and professional users across Western Europe, North America, and emerging markets. Its brands include Callebaut, Cacao Barry, and Van Houten, spanning chocolates, cocoa, fillings, and ingredients.
Key financials Revenue fell -7% while EPS surged 179%, reflecting cost discipline and margin recovery. Profitability metrics show ROE 9%, ROA 3%, and ROCE 17%, with net margins at 2%. Leverage is high (Debt/Equity 2.08) but interest coverage is thin at 1.80x.
Stock health Momentum is mixed: +2% over 3m but -12% over 6m, with a -25% drawdown from the 52w high. RSI(14) sits at 53, indicating neutral momentum. Income yield is 3%, supported by a 66% payout ratio.
Price vs fair value Barry Callebaut trades at a PREMIUM of 1.00% to our fair-value estimate and a PREMIUM of 0.60% to the consensus 12-month target. - Forward P/E of 15.15x vs trailing 25.29x signals earnings recovery expectations (Valuation 73.9th percentile). - SIDERAVIA Valuation score of 73.9/100 indicates strong relative cheapness despite the premium. - High FCF yield of 45% suggests cash generation strength, offsetting leverage concerns. - Analyst count of 12 supports near-term price alignment with targets.
Looking forward Forward PEG of 0.23 implies undemanding growth valuation, but weak 6m momentum (-12%) and thin interest coverage (1.80x) warrant caution. Growth score of 59% ranks above average, yet Quality (45%) and Strength (45%) trail, balancing the outlook.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.